Lavo Life Sciences

lavo.ai
loader linkedin-sq

Services

Lavo Life Sciences offers a range of services aimed at accelerating drug development through advanced simulations. These services include Force Field Optimization, Polymorph Ranking, Thermodynamics predictions, and Cloud Computing solutions. By utilizing AI-accelerated quantum chemistry, the company provides robust pharmaceutical property predictions incorporating hyper-accurate finite-temperature effects. Their offerings are designed to save time and money in laboratory experiments for pharma companies.

Industry and Sector

Lavo Life Sciences operates within the healthcare industry, specifically focusing on drug discovery and delivery. The company uses AI-accelerated chemistry simulations to assist pharmaceutical companies in developing new drugs. Their advanced simulation tools help predict the behavior of drug molecules at the atomic scale, expediting the process of bringing effective therapies to patients.

Y-Combinator Batch

Lavo Life Sciences is part of the Y-Combinator Winter 2023 (W23) batch. Being associated with Y-Combinator, a well-known startup accelerator, provides them with essential mentorship, funding, and networking opportunities to scale their innovative solutions in drug development.

Technology and Innovations

Lavo Life Sciences leverages AI-accelerated quantum chemistry to understand molecular crystal polymorphism and predict pharmaceutical properties. Their technology makes these predictions cheaper and more robust than existing methods. The software developed by Lavo Life Sciences simulates drug behavior at the atomic level and is scalable on the cloud for rapid turnaround times. These innovations aim to bring efficiency and cost-effectiveness to the drug development process.

Report inaccurate information

Companies similar to Lavo Life Sciences

Medium Biosciences

medium.bio

Medium Biosciences, based in Boston, MA, is a healthcare company focusing on industrial bio, developing AI models to innovate biomolecule performance.

PostEra

postera.ai

PostEra, based in Boston, MA, leverages machine learning to enhance medicinal chemistry, focusing on drug discovery and delivery within the healthcare industry.

+13

1910 Genetics

1910genetics.com

1910 Genetics, based in Cambridge, MA, integrates AI with proprietary data to advance drug discovery in neurological, autoimmune diseases, and cancer, aiming to make undruggable targets obsolete.

+21

Yoneda Labs

yonedalabs.com

Yoneda Labs, formerly known as ReAgentAI and YonedaLabs, is a San Francisco-based company that provides software to optimize chemical reactions using machine learning, focusing on the biotech industry.

Atomwise

atomwise.com

Atomwise, based in San Francisco, CA, leverages artificial intelligence to revolutionize drug discovery, focusing on small-molecule drug candidates in immunology and oncology.

+35

TandemAI

tandemai.com

TandemAI provides an integrated drug discovery platform combining AI and physics-based tools, aimed at democratizing access to advanced drug discovery technologies. The company recently raised $35 million in Series A financing to enhance its computational and experimental capabilities.

+9

Exscientia

exscientia.ai

Exscientia is a UK-based company that leverages AI to enhance the drug discovery process, notably reducing design time for candidate molecules and achieving the milestone of developing the first AI-designed molecules to enter clinical trials.

+205

Isomorphic Labs

isomorphiclabs.com

Isomorphic Labs, founded in 2021, is an Alphabet subsidiary leveraging AI and computational methods, including their development of AlphaFold 3, to revolutionize drug discovery.

+59

Terray Therapeutics

terraytx.com

Terray Therapeutics, founded in 2022, leverages AI to accelerate small molecule drug discovery, supported by a vast experimental dataset and rapid design-make-test-analyze cycles.

+23

Intelligencia

intelligencia.ai

Intelligencia offers AI-powered solutions to de-risk drug development and enhance decision-making, providing SaaS products like Portfolio Optimizer and Clinical Development Insights. Founded in 2017 and headquartered in New York, the company specializes in data and insights for clinical development, employing 110 individuals globally.